Supplementary Table S4 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
crossref（2024）
摘要
Table S4: Summary of ARO-HIF2 Urine Pharmacokinetic Parameters
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要